<DOC>
	<DOCNO>NCT01721200</DOCNO>
	<brief_summary>This study randomize control trial design examine efficacy educational decision support tool patient rheumatoid arthritis continue active disease despite use traditional disease modify drug . The study take place Geisinger Medical Center Danville , PA . Eligible subject identify treat physician provide consent randomize usual care versus use decision support tool .</brief_summary>
	<brief_title>`` Learning About Biologics '' -Rheumatoid Arthritis</brief_title>
	<detailed_description>Data suggest undertreatment rheumatoid arthritis ( RA ) patient may part due inadequate decision support face whether start biologic therapy . No proven way exist inform support RA patient candidate biologic therapy . Communicating information biologic medication particularly challenge sheer number risk disclose , difficulty explain risk extremely rare adverse event ( AEs ) , tendency people discount ( underweight ) future benefit . Dr Liana Fraenkel Yale University Primary Investigator developer theory-based high quality decision support tool effectively inform RA patient candidate biologics . Dr. Eric Newman Principal Investigator project conduct Geisinger Medical Center . All subject enrol complete baseline survey randomize use decision support tool usual care . Those randomized usual care offer opportunity access tool enrollment close follow-up visit complete . Outcomes assess two six week baseline visit Geisinger Telephone Survey Interviewing Facility . This facility equip 12 computer run two shift day . The Survey Unit use state-of-the-art Windows base Computer Assisted Telephone Interview ( CATI ) system administer survey collect research data . The group hold 12 interviewer license CATI system . Trained experienced interviewer available make call 9 9 pm Monday Friday 10 2 pm Saturdays .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Subjects must least 18 year age Able speak read English Meet revise American College Rheumatology criterion diagnosis RA Have active disease warrant initiation new biologic ( small molecule FDAapproved ) therapy determine rheumatologist Fail meet inclusion criterion Have current infection Have cancer type diagnose within past five year ( except nonmelanoma skin cancer ) Have history lymphoma , leukemia , melanoma Have chronic inflammatory disease ( addition rheumatoid arthritis ) require treatment immunosuppressive medication Have chronic liver disease due hepatitis C B Are HIV positive Have positive screen test tuberculosis ( tuberculin skin test interferongamma release assay ) radiographic lesion suggestive inactive tuberculosis complete adequate course chemoprophylactic therapy Are hear visually impair Are schedule surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>web base interactive learning tool</keyword>
</DOC>